UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.407

Sortiert nach

Data resources for the identification and interpretation of actionable mutations by clinicians

Annals of oncology, 2017-05, Vol.28 (5), p.946-957

2017

Link zum Volltext

Verfügbarkeit prüfen

Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR- mutated non-small-cell lung cancer

Current oncology (Toronto), 2020-12, Vol.27 (6), p.321-329

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients

Gynecologic oncology, 2019-05, Vol.153 (2), p.304-311

2019

Link zum Volltext

Verfügbarkeit prüfen

A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2021-07, Vol.157, p.21-29

2021

Link zum Volltext

Verfügbarkeit prüfen

A Canadian guideline on the use of next-generation sequencing in oncology

Current oncology (Toronto), 2019-04, Vol.26 (2), p.e241-254

2019

Link zum Volltext

Verfügbarkeit prüfen

The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada

Current oncology (Toronto), 2019-12, Vol.26 (6), p.353-360

2019

Link zum Volltext

Verfügbarkeit prüfen

Evidence-based best practices for EGFR T790M testing in lung cancer in Canada

Current oncology (Toronto), 2018-04, Vol.25 (2), p.163-169

2018

Link zum Volltext

Verfügbarkeit prüfen

Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot study

Current oncology (Toronto), 2019-12, Vol.26 (6), p.e717-732

2019

Link zum Volltext

Verfügbarkeit prüfen

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)

Gynecologic oncology, 2017-02, Vol.144 (2), p.250-255

2017

Link zum Volltext

Verfügbarkeit prüfen

Crizotinib inhibition of ROS1- positive tumours in advanced non-small-cell lung cancer: a Canadian perspective

Current oncology (Toronto), 2019-08, Vol.26 (4), p.e551-557

2019

Link zum Volltext

Verfügbarkeit prüfen

OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing

Current oncology (Toronto), 2019-10, Vol.26 (5), p.e618-623

2019

Link zum Volltext

Verfügbarkeit prüfen

Multiple effects of childhood deafness on cortical activity in children receiving bilateral cochlear implants simultaneously

Clinical neurophysiology, 2011-04, Vol.122 (4), p.823-833

2011

Link zum Volltext

Verfügbarkeit prüfen

Genomic Profiling and Matched Therapy for Recurrent or Metastatic Malignant Salivary Gland Tumors (MSGT): Preliminary Results

International journal of radiation oncology, biology, physics, 2016-03, Vol.94 (4), p.947-948

2016

Link zum Volltext

Verfügbarkeit prüfen

S158: FINAL RESULT OF TKI DISCONTINUATION TRIAL WITH DASATINIB FOR SECOND ATTEMPT OF TREATMENT FREE REMISSION AFTER FAILING FIRST ATTEMPT WITH IMATINIB: TREATMENT‐FREE REMISSION ACCOMPLISHED BY DASATINIB

HemaSphere, 2022-06, Vol.6, p.59-60

2022

Link zum Volltext

Verfügbarkeit prüfen

The role of molecular microsatellite identity testing to detect sampling errors in prenatal diagnosis

Prenatal diagnosis, 2010-08, Vol.30 (8), p.746-752

2010

Link zum Volltext

Verfügbarkeit prüfen

Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith–Wiedemann syndrome

Human molecular genetics, 2002-05, Vol.11 (11), p.1317-1325

2002

Link zum Volltext

Verfügbarkeit prüfen

1353P Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations

Annals of oncology, 2023-10, Vol.34, p.S778-S778

2023

Link zum Volltext

Verfügbarkeit prüfen

The in vivo delivery of heterologous proteins by microencapsulated recombinant cells

Trends in Biotechnology, 1999-02, Vol.17 (2), p.78-83

1999

Link zum Volltext

Verfügbarkeit prüfen

77TiP From liquid biopsy to cure: Using CtDNA detection of minimal residual disease to identify patients for curative therapy after non-small cell lung cancer (NSCLC) resection

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S736-S736

2021

Link zum Volltext

Verfügbarkeit prüfen

P2.09-28 Effect of TP53 Variants in HER2-mutated Non-Small Cell Lung Cancer (NSCLC)

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S343-S344

2023

Link zum Volltext

Verfügbarkeit prüfen

Functional disomy of Xp: Prenatal findings and postnatal outcome

American journal of medical genetics. Part A, 2005-05, Vol.134A (4), p.393-398

2005

Link zum Volltext

Verfügbarkeit prüfen

805P Clinically actionable alterations in adolescents and young adults (AYA) with gynaecological cancers

Annals of oncology, 2021-09, Vol.32, p.S764-S764

2021

Link zum Volltext

Verfügbarkeit prüfen

191TiP Accelerating lung cancer diagnosis through liquid biopsy

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S801-S802

2021

Link zum Volltext

Verfügbarkeit prüfen

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S420-S420

2021

Link zum Volltext

Verfügbarkeit prüfen

Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation

Annals of hematology, 2024-04, Vol.103 (4), p.1187-1196

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 2.407

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.872)
Mit Volltextzugriff
(1.984)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.110)
Life Sciences & Biomedicine
(1.009)
Humans
(816)
Male
(362)
Female
(361)
Biological And Medical Sciences
(298)
Middle Aged
(271)
Respiratory System
(260)
Medical Sciences
(225)
Adult
(216)
Aged
(203)
Biochemistry & Molecular Biology
(159)
Animals
(151)
Chronic Obstructive Pulmonary Disease
(120)
General & Internal Medicine
(110)
Pneumology
(91)
Emphysema
(81)
Fundamental And Applied Biological Sciences. Psychology
(80)
Orthopedics
(69)
Aged, 80 And Over
(68)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Data resources for the identification and interpretation of actionable mutations by clinicians

Consensus recommendations for optimizing biomarker testing to identify and treat advanced EGFR- mutated non-small-cell lung cancer

Impact of somatic molecular profiling on clinical trial outcomes in rare epithelial gynecologic cancer patients

A phase I study of binimetinib (MEK 162), a MEK inhibitor, plus carboplatin and pemetrexed chemotherapy in non-squamous non-small cell lung cancer

A Canadian guideline on the use of next-generation sequencing in oncology

The Somatic Curation and Interpretation Across Laboratories (SOCIAL) project-current state of solid-tumour variant interpretation for molecular pathology in Canada

Evidence-based best practices for EGFR T790M testing in lung cancer in Canada

Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot study

Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC)

Crizotinib inhibition of ROS1- positive tumours in advanced non-small-cell lung cancer: a Canadian perspective

OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing

Multiple effects of childhood deafness on cortical activity in children receiving bilateral cochlear implants simultaneously

Genomic Profiling and Matched Therapy for Recurrent or Metastatic Malignant Salivary Gland Tumors (MSGT): Preliminary Results

S158: FINAL RESULT OF TKI DISCONTINUATION TRIAL WITH DASATINIB FOR SECOND ATTEMPT OF TREATMENT FREE REMISSION AFTER FAILING FIRST ATTEMPT WITH IMATINIB: TREATMENT‐FREE REMISSION ACCOMPLISHED BY DASATINIB

The role of molecular microsatellite identity testing to detect sampling errors in prenatal diagnosis

Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith–Wiedemann syndrome

1353P Effect of TP53 co-mutation in non-small cell lung cancer (NSCLC) with driver mutations

The in vivo delivery of heterologous proteins by microencapsulated recombinant cells

77TiP From liquid biopsy to cure: Using CtDNA detection of minimal residual disease to identify patients for curative therapy after non-small cell lung cancer (NSCLC) resection

P2.09-28 Effect of TP53 Variants in HER2-mutated Non-Small Cell Lung Cancer (NSCLC)

Functional disomy of Xp: Prenatal findings and postnatal outcome

805P Clinically actionable alterations in adolescents and young adults (AYA) with gynaecological cancers

191TiP Accelerating lung cancer diagnosis through liquid biopsy

P35.03 Methylation Signatures Associated with T790M Status in Progressive NSCLC

Flow cytometry-based measurable residual disease (MRD) analysis identifies AML patients who may benefit from allogeneic hematopoietic stem cell transplantation

Suchergebnisse filtern